Noble Financial Sticks to Its Buy Rating for PDS Biotechnology (PDSB)
at www.tipranks.com (Thu, 28-Mar 8:25 AM)
PDS Biotechnology: Strategic Shift to Triplet Therapy Promises Enhanced Clinical Success
at www.tipranks.com (Thu, 28-Mar 7:25 AM)
PDS Biotechnology: A Strong Buy on Strategic Focus and Promising HNSCC Trial Data
at www.tipranks.com (Wed, 27-Mar 10:35 AM)
iBio, ImmunityBio, Mesoblast among healthcare movers
at seekingalpha.com (Wed, 27-Mar 10:00 AM)
Options Volatility and Implied Earnings Moves Today, March 27, 2024
at www.tipranks.com (Wed, 27-Mar 8:05 AM)
PDS Biotechnology GAAP EPS of -$1.39 beats by $0.06
at seekingalpha.com (Wed, 27-Mar 7:31 AM)
PDS Biotechnology FY 2023 Earnings Preview
at seekingalpha.com (Tue, 26-Mar 1:47 PM)
Notable earnings before Wednesday's open
at seekingalpha.com (Tue, 26-Mar 9:51 AM)
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
at www.tipranks.com (Mon, 25-Mar 8:00 AM)